Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $947.07M.
ENTERPRISE VALUE (EV)
$947.07M
Ocular Therapeutix, Inc.
Market Cap
$1.61B
Enterprise Value (EV)
$947.07M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Ocular Therapeutix, Inc. (OCUL) | $1.61B | $947.07M |
| Septerna Inc (SEPN)vs › | $1.61B | $1.55B |
| Omnicell, Inc. (OMCL)vs › | $1.61B | $1.52B |
| uniQure N.V. (QURE)vs › | $1.60B | $1.25B |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.62B | $2.11B |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.63B | $1.60B |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | $1.60B |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.57B | $1.47B |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.54B | $1.79B |
| Innoviva, Inc. (INVA)vs › | $1.54B | $1.24B |
Market Cap
$1.61B
Total Debt
$76.97M
Cash
$737.06M
Enterprise Value
$947.07M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
